Validations: Deviation Handling & Batch Definition in CM
Investigations in CM: Root-Cause and Evidence Packs Understanding Continuous Manufacturing and its Regulatory Framework Continuous Manufacturing (CM) is a transformative approach to pharmaceutical production that emphasizes efficiency, consistency, and quality assurance throughout the manufacturing process. Unlike traditional batch manufacturing, CM allows for the ongoing production of medications, facilitating more responsive medical supply chains. Regulatory authorities, including the US FDA and…
Sampling During Deviations: Where and How Much Sampling During Deviations: Where and How Much Understanding the Concept of Deviations in Continuous Manufacturing In the realm of pharmaceutical production, the term “deviation” refers to any departure from established protocols or accepted levels of quality during the manufacturing process. Understanding how deviations can impact the integrity of the product is crucial, particularly…
Material Mix-Ups in CM: Prevention and Response Material Mix-Ups in Continuous Manufacturing: Prevention and Response In the landscape of pharmaceutical manufacturing, particularly within the domains of continuous manufacturing (CM) and process analytical technology (PAT), material mix-ups pose significant risks. These risks not only jeopardize compliance with regulatory standards such as FDA process validation but also compromise patient safety. Addressing this…
Disposition Decisions: Data Packages That Stand Up In the ever-evolving landscape of pharmaceutical manufacturing, particularly in the contexts of continuous manufacturing (CM) and process analytical technology (PAT), ensuring that data packages meet regulatory expectations is pivotal. The focus has shifted toward real-time release testing (RTRT) and multivariate model validation to support process improvements and regulatory compliance. This article serves as…
Segregation and Blend Uniformity: Detecting and Correcting Segregation and Blend Uniformity: Detecting and Correcting In the pharmaceutical manufacturing industry, ensuring consistency and uniformity within product batches is paramount. This article provides a comprehensive, step-by-step tutorial on detecting and correcting issues related to segregation and blend uniformity, particularly in the context of continuous manufacturing (CM) and real-time release testing (RTRT). We…
CM Deviation Storyboards: What Inspectors Expect Continuous manufacturing (CM) and real-time release testing (RTRT) have transformed the pharmaceutical landscape, allowing for more efficient processes and improved product quality. However, the complexity of these systems can lead to deviations, necessitating robust validation practices and effective handling procedures. This tutorial aims to provide pharmaceutical professionals with a detailed guide on creating CM…
Exception Batches: Definitions, Labels, and Records Understanding Exception Batches in Continuous Manufacturing The concept of exception batches in the pharmaceutical industry, particularly within the framework of continuous manufacturing (CM) and process analytical technology (PAT), is critical for maintaining compliance with regulatory standards such as those outlined by the FDA, EMA, and MHRA. Exception batches are those that deviate from predefined…
Edge of Failure Testing in CM: How Far Is Defensible Edge of Failure Testing in Continuous Manufacturing: How Far Is Defensible Understanding Continuous Manufacturing in Pharmaceuticals Continuous Manufacturing (CM) represents a transformative approach in pharmaceutical production, advancing efficiency and product quality. Defined as a method where raw materials are continuously fed into the production process and products are continuously removed,…
Edge of Failure Testing in Continuous Manufacturing: How Far Is Defensible The pharmaceutical industry is undergoing a significant transformation with the integration of Continuous Manufacturing (CM) processes and Process Analytical Technology (PAT). As these advanced technologies become commonplace, it’s crucial to understand the implications and requirements surrounding failure testing in CM. This article provides a comprehensive tutorial detailing the definitions,…
Handling Sensor/Model Failures Mid-Run Handling Sensor/Model Failures Mid-Run in Continuous Manufacturing Continuous manufacturing (CM) has become increasingly prevalent in the pharmaceutical industry, allowing for more efficient production and enabling real-time release testing (RTRT) of products. As part of this innovative manufacturing approach, robust engineering and validation frameworks are necessitated by regulatory entities such as the FDA, EMA, and MHRA. One…